Fig. 5From: An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsDisplay (multidimensional scaling (MDS)) of sample risk stratification based on 14q32 prognostic miRNAs. a MDS of the Boston cohort using 18 miRNAs. b MDS of the Utah cohort using 14 miRNAs that were mapped on the Agilent array. Yellow/blue color represents sample risk assignments according to the 5-miRNA prognostic model. Classification was highly concordant between the 5 and the 18 miRNA setBack to article page